Holly S. Geres, BS

Assistant Director
Duke Clinical Research Institute
Durham, North Carolina, United States

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 84 - Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections

  Thursday, October 17, 2024
  11:00 AM – 11:15 AM US PT